Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition that causes muscle pain and pronounced stiffness, especially in the shoulders and hips. Symptoms of PMR disease often appear suddenly — sometimes literally overnight — but in some people they develop gradually over several days or weeks.
Pain and stiffness are typically bilateral, worse in the morning or after rest, and improve with movement. In more severe cases, morning stiffness can make it difficult to get out of bed, lift the arms, or get dressed.
Although PMR is highly treatable, it is often misinterpreted as aging, overuse, or fibromyalgia, which delays diagnosis. Early recognition is crucial because PMR can be associated with giant cell arteritis (GCA), a potentially serious vascular condition.
This guide explains the core symptoms, causes, diagnostic criteria, and treatment options for polymyalgia rheumatica, written in a clear, patient‑friendly format.
Key Clinical Points – Polymyalgia Rheumatica (PMR)
- Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition causing pain and stiffness in the shoulders, hips, and neck.
- The condition typically affects adults over 50 and is associated with elevated ESR and CRP values.
- Diagnosis is based on characteristic symptoms, raised inflammatory markers, exclusion of mimicking diseases, and a rapid response to corticosteroids.
- First-line treatment consists of low to moderate doses of prednisone (10–20 mg), with most patients improving within 24–48 hours.
- Giant cell arteritis (GCA) may coexist with PMR and requires urgent recognition due to the risk of vision loss.
- Most patients achieve excellent symptom control and gradually taper steroids over 1–2 years, though some require longer therapy.
What Is Polymyalgia Rheumatica (PMR)?
In medical terms polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition characterized by inflammation of the joint linings (synovitis) and tendon sheaths (tenosynovitis). PMR disease is immune‑mediated, but unlike many other rheumatic disorders, it does not involve autoantibodies directed against the body’s own tissues. This makes PMR distinct from conditions such as rheumatoid arthritis or systemic autoimmune diseases.
Although inflammation is present, it is never as aggressive as in rheumatoid arthritis and does not cause permanent joint or tendon damage.
Because PMR occurs almost exclusively in older adults, current evidence suggests that the disease is linked to age‑related changes in immune regulation, making the immune system more prone to inappropriate inflammatory responses.
Key features include:
- sudden onset of pain and stiffness
- morning stiffness lasting >45 minutes
- difficulty lifting arms, standing up, or turning in bed
- elevated inflammatory markers (ESR, CRP)
PMR disease responds dramatically to low‑dose corticosteroids, which is both a diagnostic clue and a cornerstone of treatment.
Why Does Polymyalgia Rheumatica (PMR) Occur?
The exact cause of polymyalgia rheumatica (PMR) is still unknown. PMR disease is considered an immune‑mediated inflammatory condition, but the precise trigger that activates the immune system remains unclear.
Current research suggests that several factors may contribute to the development of PMR:
- Genetic predisposition — more common in families; associated with HLA‑DRB1\04*.
- Infection triggers — increased incidence after Mycoplasma pneumoniae, Parvovirus B19, and EBV.
- Gut–immune link — possible association with diverticulitis and altered gut microbiota.
- Post‑vaccination onset — rarely occurs after influenza vaccination due to immune activation by adjuvants.
- Age‑related immune dysregulation — PMR occurs almost exclusively in adults over 50.
Who Gets PMR & Key Risk Factors
- Age — PMR almost exclusively affects older adults, most commonly between 70 and 80 years.
- Sex — women are 2–3 times more likely to develop PMR than men.
- Race/Ethnicity — PMR is most common in white populations; it is rare in other racial and ethnic groups.
- Genetic background — higher prevalence in families; associated with HLA‑DRB1\04*.
- Immune aging — age‑related changes in immune regulation increase susceptibility.
Symptoms of Polymyalgia Rheumatica (PMR)
The most common symptoms of polymyalgia rheumatica are muscle pain and stiffness in the shoulders, neck, and hips. Pain is often present in the upper arms, the upper and lower back, and the thighs as well.
Symptoms of PMR may appear suddenly, sometimes even overnight. Patients typically feel pain on both sides of the body, in a symmetrical pattern. Because of the pain and stiffness, lifting the arms above shoulder level can be difficult. The arms and wrists may also be painful, and hip pain can make it hard for some patients to get out of bed or rise from a chair.
Pain in PMR is usually worst in the morning and gradually improves throughout the day. Long periods of inactivity — for example, sitting during a long car ride — can make stiffness worse.
Other common symptoms include:
- Night‑time pain that disrupts sleep
- Reduced range of motion in the shoulders
- Difficulty performing everyday activities such as getting out of bed or a chair, fastening a bra, putting on socks and shoes, showering, combing hair, or driving
- General fatigue
- Weakness, loss of appetite, weight loss, chills, or a mild fever
About a quarter of patients experience pain and swelling in the wrists and hands. This is caused by inflammation of the joints and tendon sheaths. Hand swelling may resemble rheumatoid arthritis and can raise suspicion of that diagnosis. Swelling of the wrist tendons may also lead to carpal tunnel syndrome, causing tingling or numbness in the hands.
PMR Diagnosis
Diagnosing polymyalgia rheumatica (PMR) can be challenging because its symptoms often resemble other conditions, and there is no single test that can confirm the diagnosis. PMR diagnosis is usually based on a combination of characteristic symptoms, clinical examination, and laboratory findings that support the presence of inflammation.
PMR should be considered in adults over 65 who previously functioned normally but suddenly develop severe pain and stiffness that make even basic daily activities difficult.
Medical History and Clinical Examination
During the consultation, patients typically describe the symptoms outlined in the previous section. PMR should be suspected when symptoms last longer than 2–3 weeks, the patient is over 50 (most commonly over 65), and morning stiffness lasts more than 45 minutes.
On physical examination, clinicians may observe:
- The patient is unable to fully lift the arms due to pain
- Difficulty rising from a chair, often using the arms for support
- Painful or limited wrist movement due to swelling
- Some patients cannot fully close their fists
- Visible swelling of the hands may be present
- Tenderness over the shoulders, upper back muscles, upper arms, and thighs
- Despite the sensation of weakness, true muscle weakness is not found on examination
Laboratory Tests
Almost all patients with PMR have elevated inflammatory markers, including erythrocyte sedimentation rate (ESR) and CRP. ESR is often above 40 mm/h. Higher inflammatory values usually correlate with more pronounced systemic symptoms such as fatigue, chills, and weight loss.
Blood tests in PMR are typically negative for:
- Rheumatoid factor (RF)
- Anti‑cyclic citrullinated peptide antibodies (anti‑CCP)
These results help distinguish PMR from rheumatoid arthritis, which commonly shows positive RF or anti‑CCP.
Although inflammatory markers are elevated in both PMR and rheumatoid arthritis, the levels in PMR are rarely as high as those seen in rheumatoid arthritis.
Imaging (Ultrasound and MRI)
Ultrasound can detect:
- Inflammation of tendons and bursae around the shoulders
- Joint effusion within the shoulder joint
- Swelling of the wrist and hand tendons
- Signs of nerve swelling in the carpal tunnel if present
MRI can show similar findings—bursitis, tendon inflammation, or joint effusion—but is more sensitive for detecting changes in the hips and pelvic region, where PMR often causes deep, difficult‑to‑localize pain.
Diseases That Mimic Polymyalgia Rheumatica (PMR)
Polymyalgia rheumatica (PMR) has non‑specific symptoms that can resemble many other conditions. When evaluating a patient with shoulder, hip, or neck pain and stiffness, it is important to consider other disorders that may present with similar features.
Conditions that can mimic PMR include:
- Rheumatoid arthritis — especially elderly‑onset RA, which may present with shoulder and wrist swelling.
- Other inflammatory rheumatic diseases — spondyloarthritis, lupus, scleroderma, vasculitis.
- Shoulder disorders — rotator cuff tears, shoulder arthritis, frozen shoulder, impingement syndrome.
- Spinal spondylosis — cervical or lumbar degenerative changes causing referred pain.
- Infections — viral or bacterial infections, including endocarditis.
- Fibromyalgia — widespread pain and fatigue without elevated inflammatory markers.
PMR and Giant Cell Arteritis (GCA)
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are closely related inflammatory conditions that often occur together. They share similar immune mechanisms and typically affect the same age group, which is why symptoms may overlap.
In some patients, PMR represents the muscular manifestation of a broader inflammatory process, while in others GCA appears suddenly and requires urgent recognition due to the risk of vision loss.
Why PMR and GCA Often Occur Together
- Both conditions belong to the same inflammatory disease spectrum.
- They share similar immune pathways, including T‑cell activation and cytokine‑driven inflammation.
- They most commonly affect older adults, especially women.
- Inflammation can involve periarticular structures (PMR) or large arteries, particularly the temporal arteries (GCA).
- Symptoms may overlap, making careful evaluation essential.
Key Symptoms of GCA
- New, severe headache, often in the temporal region
- Jaw pain while chewing (jaw claudication)
- Visual disturbances — blurred vision, double vision, transient vision loss
- Scalp tenderness, discomfort when touching or combing the hair
- Systemic symptoms: fatigue, loss of appetite, weight loss, fever
- Coexisting shoulder and hip pain and stiffness due to PMR
When to Seek Urgent Medical Attention
GCA is a medical emergency because it can cause permanent vision loss. Immediate medical evaluation is needed if any of the following occur:
- Sudden visual changes
- A new or rapidly worsening headache
- Jaw pain during chewing
- Marked tenderness over the temples
- PMR symptoms combined with any of the above warning signs
Prompt diagnosis and treatment of GCA are crucial for preventing serious complications, especially those affecting vision.
Polymyalgia Rheumatica Treatment
The cornerstone of polymyalgia rheumatica treatment is the use of low to moderate doses of corticosteroids, most commonly prednisone (e.g., Decortin) in doses around 10–20 mg. These medications are highly effective and typically lead to a rapid and dramatic improvement in symptoms.
Most patients notice clear relief within 24–48 hours of starting therapy. When the diagnosis is correct, many describe the improvement as if the symptoms “disappeared overnight.” Some individuals, however, may need 2–4 weeks to experience the full therapeutic effect.
Within three to four weeks, patients should feel at least a 70% reduction in symptoms, and inflammatory markers such as ESR and CRP should normalize or significantly decrease. If this does not occur, treatment should be reassessed and other possible causes of symptoms considered.
Once symptoms improve, patients should continue taking medicine in a slightly lower dose, around 10 mg of prednisone daily, as advised by their doctor.
Dose tapering usually begins 4–6 weeks after starting treatment. The goal is to discontinue corticosteroids within one year if symptoms remain absent, although some patients require therapy for 2–3 years. Relapses can occur and may require temporary dose adjustments.
Corticosteroids must not be stopped abruptly, as this can lead to a return of symptoms.
Medications That Are Not Effective
Non‑steroidal anti‑inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, or diclofenac are not effective for PMR. Combination analgesics containing tramadol or paracetamol (e.g., Zaldiar, Doreta, Lekadol) also do not provide meaningful relief.
Corticosteroid Side Effects
Because long‑term corticosteroid use carries risks, treatment should be given at the lowest effective dose. Common side effects include:
- Osteoporosis
- Avascular necrosis
- Increased susceptibility to infections
- Elevated blood sugar and reduced diabetes control
- Steroid‑induced myopathy
- High blood pressure
- Weight gain
- Cataracts
- Insomnia
- Easy bruising or thinning of the skin
Alternative Medications
For patients who cannot tolerate long‑term corticosteroids or experience significant side effects, other medications may be considered. These include methotrexate or hydroxychloroquine, which can help reduce steroid requirements in selected cases.
Living With Polymyalgia Rheumatica
Once treatment begins and symptoms improve, most patients with polymyalgia rheumatica can return to their usual daily routines, including exercise and regular physical activity.
Many will be able to discontinue corticosteroid therapy within 1–2 years, although some individuals may need to remain on a low maintenance dose long‑term. In a portion of patients, the disease may return even after years of remission.
Key considerations for long‑term management:
- Calcium and vitamin D supplementation — recommended during corticosteroid therapy to help prevent bone loss and reduce fracture risk.
- Osteoporosis prevention — patients at higher fracture risk may benefit from osteoporosis medications such as bisphosphonates.
- Monitoring for side effects — watch for signs of corticosteroid‑related complications and report any concerns to a healthcare professional.
- Gradual return to activity — most patients can resume normal activities once pain and stiffness improve.
- Awareness of relapse — symptoms can occasionally return, even after long symptom‑free periods.
Living with PMR is manageable for most people, especially once the initial inflammation is controlled. With appropriate treatment, bone protection strategies, and regular follow‑up, patients can maintain a high quality of life and remain active without significant limitations.
FAQ for PMR
Fibromyalgia vs polymyalgia rheumatica
Fibromyalgia causes widespread, chronic pain, normal inflammatory markers, sleep disturbance, and heightened pain sensitivity. Polymyalgia rheumatica (PMR) causes pain and stiffness in the shoulders and hips, elevated ESR/CRP, and shows a rapid response to corticosteroids, which fibromyalgia does not.
In conclusion, PMR is an inflammatory condition, whereas fibromyalgia is not.
Polymyalgia rheumatica foods to avoid
There is no strict PMR diet, but many patients choose to limit foods that may promote inflammation, such as:
- processed sugars
- fried and ultra‑processed foods
- trans fats
- excessive alcohol
A balanced, anti‑inflammatory diet may support overall health.
What is PMR in medical terms
Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disorder characterized by pain and stiffness in the shoulders, hips, and neck, typically accompanied by elevated inflammatory markers and a strong response to corticosteroid therapy.
Polymyalgia rheumatica life expectancy
PMR does not reduce life expectancy. With appropriate treatment and monitoring, most patients maintain a normal lifespan. Risk increases only if giant cell arteritis (GCA) develops, due to potential vision complications.
Polymyalgia rheumatica specialists
PMR is most commonly diagnosed and managed by:
- rheumatologists
- primary care physicians in collaboration with rheumatology
- internal medicine specialists for complex cases
Polymyalgia rheumatica test
There is no single test that confirms PMR. Diagnosis relies on:
- characteristic symptoms
- elevated ESR and CRP
- exclusion of other conditions
- rapid improvement after corticosteroids
Is polymyalgia rheumatica an autoimmune disease
PMR is considered an autoimmune or immune‑mediated inflammatory condition, although the exact cause remains unclear. The immune system triggers inflammation in periarticular tissues.
Polymyalgia rheumatica vs rheumatoid arthritis
- PMR: shoulder and hip girdle pain, elevated inflammatory markers, negative RF/anti‑CCP, dramatic steroid response.
- Rheumatoid arthritis (RA): small joint inflammation (hands/feet), positive RF/anti‑CCP, joint erosions, chronic synovitis.
In conclusion, inflammatory markers are elevated in both conditions, but they are typically much higher in rheumatoid arthritis than in PMR. PMR rarely causes true joint effusion and primarily affects the shoulders and hips, whereas rheumatoid arthritis predominantly involves the small joints of the hands and feet.
What is the newest treatment for polymyalgia rheumatica
Standard therapy remains corticosteroids, but newer approaches include:
- steroid‑sparing agents such as methotrexate
- ongoing research into biologic therapies (e.g., IL‑6 inhibitors) for relapsing or difficult‑to‑treat PMR
Natural remedies for polymyalgia rheumatica
Natural strategies may complement medical treatment:
- gentle physical activity
- anti‑inflammatory diet
- adequate sleep
- stress‑reduction techniques
- calcium and vitamin D supplementation when appropriate
These do not replace medical therapy but may support overall well‑being.
Diet for polymyalgia rheumatica
Commonly recommended dietary patterns include:
- Mediterranean diet
- high intake of fruits, vegetables, whole grains, and omega‑3 fats
- limiting processed foods and sugars
- adequate protein to maintain muscle mass
